Ann: Dr Bains Appointment and Initial Director's Interest Notice, page-8

I would also like this

It has been actually not been easy to buy IPD on any small pullbacks for the past few months even.

The biotech overall market star is also rising.
I think recognition must flow through to the best stocks on the asx.

ImpediMed has not had much restless urgent buying as yet - buyers maybe have thought that they have still had time to get in at bottom level or thought to consider buying more on the next pullback.

In reality it is almost impossible to perfectly time any market,
Next thing can be we be thinking to buy more on pullbacks higher!

Excellent that the new Ceo, also MD , has begun.
Notably she was also past CEO / COO for NEU

Thank goodness we now are into 2024 & the real performance ahead for ImpediMed at last.
Q2 reporting and Q3 projections are ahead-
Thankyou to all- grateful as ever for excellent research herein .esp from Acclivity , 2Dogs, & others.